Your shopping cart is currently empty

TLR7/8 agonist 6 is a potent dual TLR7 and TLR8 agonist, activating the innate immune system and inducing cytokine production.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $187 | - | In Stock | |
| 5 mg | $469 | - | In Stock | |
| 10 mg | $762 | - | In Stock | |
| 25 mg | $1,520 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $518 | - | In Stock |
| Description | TLR7/8 agonist 6 is a potent dual TLR7 and TLR8 agonist, activating the innate immune system and inducing cytokine production. |
| In vitro | In cellular assays, TLR7/8 agonist 6 effectively induces the secretion of high levels of IFN-alpha and other pro-inflammatory cytokines in human PBMCs and reporter cell lines [1]. |
| In vivo | Administration of TLR7/8 agonist 6 in animal models significantly enhances antigen-specific T-cell and B-cell immune responses when utilized as a vaccine adjuvant [1]. |
| Molecular Weight | 417.5 |
| Formula | C24H27N5O2 |
| Cas No. | 2115702-83-3 |
| Smiles | O=C(OC)C=1C=CC2=C(N=C(N)C=3N=C(N(C32)CC4=CC=C(C=C4)CN)CCCC)C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 16 mg/mL (38.32 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.